| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 740259 | Null | 0.0208632511155816 | -0.11704968 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0208632511155816 | -0.17261852 |
| NSC 740602 | Null | 0.0208632511155816 | -0.2785098 |
| NSC 756166 | GSK312948A | 0.0208632511155816 | -0.19290293 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0208632511155816 | -0.035087327 |
| NSC 125066 | Bleomycin sulfate | 0.0208632511155817 | 0.36910832 |
| NSC 125347 | Null | 0.0208632511155817 | -0.15370078 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0208632511155817 | -0.10467538 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0208632511155817 | -0.10858989 |
| NSC 276382 | PEPLEOMYCIN | 0.0208632511155817 | 0.32031065 |